Microbiome study recruiting participants
Emory School of Medicine's Microbiota Enrichment Program is recruiting participants for a healthy volunteer’s gut/microbiome study. The study is designed to create a reference range of what a normal healthy gut microbiota looks like. Undergraduate and graduate students, as well as faculty and staff would potentially be eligible to participate, as the age range is 18 - 40. More information Master of Science in Clinical Research Courses: Advanced data management
Faculty and postdocs are welcome to enroll in a fall semester course which is part of the curriculum in the Master of Science in Clinical Research degree program in the Laney Graduate School. Tuition awards are not available, but Emory faculty and postdocs may be eligible for the Emory Courtesy Scholarship which would cover tuition for the course. This is a semester-long course which meets on Thursdays, from 10:00 to 11:50 am. from August 29 until December 5, 2019. Prerequisite: Completion of or concurrent enrollment in a basic statistics course covering at least linear regression (BIOS/MSCR 500 or equivalent). Read more | Questions Researchers: Want medical student assistance on your project?
The five-month Discovery Phase of the Emory University School of Medicine curriculum provides medical students with the opportunity to conduct hypothesis-driven research projects while working closely with a faculty mentor. If you have a research project that a medical student could assist with, please submit your project information here by
Friday, 8/23. The Office of Research will compile a list of project titles to share with medical students at this year’s Discovery Research Fair on Wednesday, 8/28. Questions Need help navigating the Department of Medicine Research Administration Service (RAS) Unit? The DOM RAS Unit has issued a one-page document to assist you in working your way through the grant submission process starting with pre-award. Download PDF
Research Scientist and Clinical Investigator PATHS:
Whether you are a clinical educator, clinical investigator or research scientist, PATHS will guide you through additional learning opportunities to aid in your career progression. These guidelines detail suggested targeted accomplishments towards promotion with a specific time frame. Each PATH is divided by career year(s) into best practices and academic mission areas. Read more
Funding & Award Opportunities
Weekly NIH funding opportunities and notices
Federal funding opportunities for public health faculty
Searchable database of internal medicine funding opportunities CF lung transplant consortium awards
Deadline: Friday 8/2 (LOI) The objective of this proposal is the establishment of a clinical and translational research network of CFLTC to facilitate the study of lung transplant for CF and other lung diseases to improve access, clinical care, and long-term outcomes of individuals with CF who undergo lung transplant. Read more
HIV/HCV no co-infection (NoCo) 2019 program
Deadline: Friday 8/9 This FOA supports the research efforts of academic institutions, clinical investigators, community organizations and research networks to help inform the scientific community about barriers and facilitators of HCV elimination, including micro-elimination in people living with HIV. Targeting micro-elimination of HCV in HIV-infected or high-risk HIV-uninfected individuals is a feasible and a more proximate short-term goal and a positive step toward more global HCV elimination. Read more
NIH director’s early independence awards (DP5 clinical trial optional)
Deadline: Tuesday 8/13 (LOI) This FOA supports exceptional investigators who wish to pursue independent research essentially after completion of their terminal doctoral/research degree or end of post-graduate clinical training, thereby forgoing the traditional post-doctoral training period and accelerating their entry into an independent research career. Read more NIH Lasker clinical research scholars program
Deadline: Friday 8/30 The program supports a small number of exceptional clinical researchers in the early stages of their careers to promote their development to fully independent positions. Successful candidates are designated as Lasker Clinical Research Scholars. Read more Focused projects award for junior investigators
Deadline: Monday 9/2 This FOA supports projects across a wide variety of topics and research questions relevant to sleep medicine that align with the mission of the American Academy of Sleep Medicine (AASM) Foundation. Read more
American Gastrointestinal Association - Pfizer pilot research award in inflammatory bowel disease (IBD)
Deadline: Wednesday 9/4 The objective of this FOA is to provide funds for early career investigators to help establish their research careers or to support projects that represent new research directions for established investigators. Projects must focus on new research areas that could improve the diagnosis and treatment of IBD. Read more RFA: the role of health policy and health insurance in improving access to and performance of cancer prevention, early detection and treatment services
Deadline: Tuesday 10/15 This FOA calls for research that evaluates the impact of the many changes now occurring in the healthcare system with a focus on cancer prevention, control, and treatment. Efforts focusing on improving access to care may also impact inequities that contribute to health disparities. New health public policy initiatives such as the new federal and state marketplaces that have expanded insurance coverage, as well as Medicaid expansion in some states, create natural experiments ripe for evaluation. Read more
Scott Fridkin (Infectious Diseases) received an R01 from AHRQ (Agency for Healthcare Research and Quality) for a project entitled, “Nursing resources and health care-associated infections: measures of hospital performance." Tanvi Dhere (Digestive Diseases) received funding from Parexel International, LLC for a project entitled, “A phase III, randomized, double blind, parallel group, placebo controlled, international, multicenter study to assess efficacy and safety of Cx601, adult allogenic expanded adipose-derived stem cells (eASC), for the treatment of complex perianal fisula(s)
in patients with Crohn's disease over a period of 24 weeks and a follow-up period up to 52 weeks (ADMIRE-CD II study)." Jennifer Christie (Digestive Diseases) received funding from Allergan Sales, LLC for a project entitled, “A 52 week randomized, double blind, placebo controlled, phase 3 study to evaluate the safety and efficacy of relamorelin in patients with gastroparesis." Have you or a colleague recently received an award or grant funding?
Recent Notable Publications
Jesse Jacob (Infectious Diseases) and David Murphy (Pulmonary)
Johnston KJ, Thorpe KE, et al. “The incremental cost of infections associated with multi-drug resistant organisms in the inpatient hospital setting- A national estimate.”
Health Serv Res. 2019 Aug; 54 (4): 782-792. Read more
Marina Sorrentino Hernandes (Cardiology)
Campos ACP, Berzuino MB, Fonoff ET, Pagano RL, et al. “Monoaminergic regulation of nociceptive circuitry in a Parkinson’s disease rat model.” Exp Neurol.
2019 Aug; 318:12-21. Read more Karan Uppal, Young-Mi Go and Dean Jones (Pulmonary)
Dennis KK, Liu KH, Ma C, Liang B, et al. “Phytochelatin database: a resource for phytochelatin complexes of nutritional and environmental metals.” Database (Oxford).
2019 Jan 1;2019. pii: baz083. Read more
Would you like to highlight a recent notable publication?
Zoobiquity Conference: a species-spanning approach to medicine
Friday 9/13 | The Emory Conference Center Hotel | 8 a.m. – 4:30 p.m.
Closing reception at the Atlanta Zoo from 5:30 - 8:30 p.m. The Zoobiquity Conferences bring leaders in human and veterinary medicine, wildlife biology, conservation and evolutionary biology, and behavioral ecology together for collaborations in research, clinical care and public health. These transdisciplinary conferences create greater awareness of the species-spanning nature of health and disease and accelerated biomedical innovation through scientific collaboration between a diverse range of experts in human and animal health. More information | Register
2019 Research Day Call for Abstracts
The Department of Medicine is now accepting abstracts for the 12th annual Department of Medicine Research Day, held Friday, November 1 from 8 a.m. to 5 p.m. in the Cox Hall Ballroom. Abstracts for oral and poster presentations must be submitted by Monday, August 19 at 11:59 p.m. EST. Late submissions will not be accepted. All Department of Medicine faculty, fellows, residents, and students (whose primary mentor is a member of the Department of Medicine) are invited to submit an abstract.
There is a limit of two abstracts per presenting author.
Agenda | 2019 Prize Descriptions | Website | Questions? Registration for the event will open shortly. For questions about Research Day, please contact Hannah Joy
Aaron Trammell, MD, MSc
Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine
What is your professional background?
I was born and raised in North Carolina and attended medical school at UNC Chapel Hill. I completed my residency in internal medicine, followed by fellowship in pulmonary and critical care medicine at Vanderbilt University. I received additional clinical training in pulmonary vascular diseases in Houston before coming to Emory in 2015. In what division do you work, and who is your mentor?
I am in the Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine. My primary mentor is Mike Hart, MD, who is in the same division. I also receive mentoring from Lawrence Phillips, MD (Endocrinology). Briefly describe your research. Why is it important?
My interests center on understanding factors affecting risk of pulmonary hypertension (PH) development and poor outcome. As a fellow, I studied the role of metabolic factors in PH animal models. It is now well-established that metabolic conditions (e.g. metabolic syndrome or diabetes) are associated with the development and severity of pulmonary arterial hypertension, a rare form of PH. After coming to Emory, I completed MSCR training which laid the foundation for my current epidemiologic and translational work to understand the role of metabolic disease in more common forms of PH, such as PH that complicates common lung diseases or heart failure. These conditions are currently without treatment, and we hope to inform new approaches to evaluating and managing them. What do you like most about Emory?
The institution, my division, and my mentors have been supportive of my development via the Georgia CTSA's MSCR program, which has been fundamental to my current work. The resources and academic spirit at the Atlanta VA and at Emory have continued to push me ahead in developing and carrying out my work. What do you like to do in your spare time?
I enjoy spending time with my wife and two young but growing boys (current ages 1.5 and 5). We all enjoy weekends without calls, brunch, outdoor sports and activities, and trips to the beach. My wife and I are avid Tar Heel basketball fans and have indoctrinated our kids!
"What's Up" is brought to you by the Emory University Department of Medicine's Research Community.
View the DOM Research website here.
|